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Abstract
BACKGROUND: Mangosteen (Garcinia mangostana L.) is a plant that contains various secondary metabolite 
compounds, one of which is xanthone. Xanthone in mangosteen has a variety of beneficial biological and medical 
effects, one of which is an antioxidative, anti-inflammatory, and antiapoptotic agent.
AIM: The aim of the study was to perform the selection of any xanthone in mangosteen pericarp that have potentially 
inhibit the interaction of AGEs and RAGE.
METHODS: The analysis was made in silico by docking method using software Hex 8.0. The docking was done 
between AGEs-RAGE, also between nine active compounds of G. mangostana with RAGE. The active compounds 
analyzed here were including α-mangostin, β-mangostin, γ-mangostin, mangostanol, garcinone D, 1,6-Dihydroxy-
3,7-dimethoxy-2-(3-methylbut-2-enyl)-xanthone, gartanin, 1-isomangostin, and 3-isomangostin. Further analysis 
was performed to see the interactions formed between ligands with their receptors using software LigPlus+ and 
Discovery Studio 4.1.
RESULTS: 1-isomangostin, 3-isomangostin, γ-mangostin, mangostanol, D-garcinone, and gartanin have potentially 
could inhibit the interaction and activity of imidazole in RAGE through a competitive binding mechanism. 
CONCLUSIONS: The inhibition of imidazole-RAGE activity by the mangosteen active components may inhibit the 
pathobiology of AGEs-RAGE axis.
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Introduction
The advanced glycation end-products 
receptor (RAGE) is a member of the immunoglobulin 
superfamily, described as an interaction site for AGEs 
on the cell surface. AGEs are the end product of the 
glycation process and the protein and lipid oxidation. 
The bond between AGE and RAGE can lead to oxidative 
stress and activation of a pro-inflammatory signaling 
pathway. AGEs consist of several very heterogeneous 
components, where their number will increase in patients 
with diabetes, kidney failure, Alzheimer’s disease, and 
in the aging process. The formation of AGE consists of 
several processes; Maillard reactions are characterized 
by the formation of a brown substance produced from 
the non-enzymatic reaction of the reduction of sugars 
and amino acids on proteins [1], [2]. This reaction 
evolved from the bond between the amino group of 
proteins with the carbonyl group of sugars to form the 
Schiff bases and Amadori components, thus leading to 
the formation of various AGE derivatives [3], [4]. Some 
of the AGEs components include: N-ε-(carboxymethyl)
lysine (CML) is one of the most widely accumulated 
protein-modified AGEs in the body of patients with 
diabetes and renal failure; argpyrimidine and imidazole 
are molecules derived from arginine products; and 
pentosidine is the cross-reaction product between the 
arginine-lysin residues [5], [6].
AGEs allegedly have an important role in the 
development of complications of diabetes, cardiovascular 
disease, stroke, and microvascular disease including 
retinopathy, neuropathy, nephropathy, and other 
complications [7], [8]. Several studies have reported 
that interactions between AGE and RAGE can activate 
signaling pathways such as ERK1/ERK2 kinase and 
NF-κB [9], [10], thus regulating cellular function associated 
with the expression of various pro-inflammatory and 
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pro-thrombotic genes which are important in the 
pathogenesis of various chronic diseases [11], [12].
Garcinia mangostana L. (Guttiferae) or 
commonly known as mangosteen is a tropical plant 
originating from India, Myanmar, Malaysia, Philippines, 
Sri Lanka, and Thailand. The pericarp part of the 
mangosteen fruit has been widely used in medicine for 
the treatment of infections and skin injuries, dysentery, 
diarrhea, and anti-inflammation. Mangosteen plants 
are known to contain various secondary metabolite 
compounds, one of which is xanthones. The number 
of xanthone compounds successfully isolated from the 
mangosteen pericarp is approximately 50 species. The 
first xanthone isolated is then named as mangostin. The 
main medical and biological properties of G. mangostana 
are as antioxidant, anti-tumor, anti-inflammatory, anti-
allergic, anti-bacterial, anti-fungal, anti-malarial, and 
anti-viral compounds [13]. In this study, we will analyze 
the potential inhibition of AGE-RAGE activity by some 
of the active components of mangosteen, including 
α-mangostin, β-mangostin, γ-mangostin, mangostanol, 
garcinone D, 1,6-Dihydroxy-3,7-dimethoxy-2-(3-
methylbut-2-enyl)-xanthone, gartanin, 1-isomangostin, 
and 3-isomangostin. This study will be conducted 
through a computational analysis and 3D protein 
structure analysis. This study is important as one of 
the earliest screening methods in determining which 
the mangosteen active components have potential 
as a therapeutic agent against pathological RAGE 
in diabetes. Crude ethanol extract of G. mangostana 
pericarp potentially showed antioxidant, anti-glycation, 
DDIT3 inhibitor, and anti-apoptotic activity in goat 
cultured lenses [14].
Materials and Methods
Search for sequences of the amino acid 
and active component structure of G. mangostana 
The sequences of amino acids that make up 
the RAGE protein (GI: 2497319) were obtained from 
the National Center for Biotechnology Information 
(NCBI), United States National Library of Medicine, 
National Institute of Health (http://www.ncbi.nlm.nih.
gov) database. The 3D structure of the active compound 
components of G. mangostana and AGE components 
was obtained from PubChem Open Chemistry 
Database. There are nine active compounds, including 
α-mangostin (CID: 5281650), β-mangostin (CID: 
5495925), mangostanol (CID: 10048103), garcinone 
D (CID: 5495926), 1,6-Dihydroxy-3,7-dimethoxy-
2-(3-methylbut-2-enyl)-xanthone (CID: 5316764), 
gartanin (CID: 5281633), γ-mangostin (CID: 5464078), 
1-isomangostin (5281641), and 3-isomangostin 
(13873655). In addition, there are four AGE compounds 
including CML (CID: 123 800), argpyrimidine (CID: 
17750123), imidazole (CID: 795), and pentosidine (CID: 
119593). The 3D structures of the active components of 
G. mangostana and AGE were obtained in the form of 
*.sdf file format, which will then be converted to *.pdb 
files using OpenBabel software [15].
Protein 3D structure modeling
The 3D structure modeling of RAGE was 
predicted using SWISS-MODEL webserver by 
homology modeling method [16], [17]. The 3D structure 
of the protein was then validated by the Ramachandran 
plot analysis.
Docking and visualization between 
proteins-ligands
Simulation of docking between AGE-RAGE as 
well as between the active components of G. mangostana 
L. with RAGE was performed using HEX 8.0 software 
[18]. The docking protocol consists of three stages of 
visualization, namely, rigid body energy minimization, 
semi-flexible repair, and finishing refinement in explicit 
solvent. Docking results were then visualized with 
Chimera 1.6.2 and Discovery Studio 4.1 software.
Analysis of binding interactions between 
proteins and ligands
The results of the next docking analysis will 
be visualized using Discovery Studio 4.1, LigPlot+ [19] 
and LigandScout 3.1 [20] software. An interaction 
between proteins and ligands was analyzed to see the 
amount and type of bonds formed, such as hydrogen 
bonds, hydrophobic bonds, and Van der Waals bonds. 
Pharmacophore analysis was also performed to see 
the residues directly involved in the interaction process, 
as well as the minimization energy analysis to improve 
the structure and shape of the molecule during the 
interaction.
Results
The interaction between AGEs and RAGE
It appears that all AGEs bind to the Ig-like 
C2-type 1 domain of RAGE (Figure 1a). The possible 
interaction between AGEs (CML, pentosidine, 
argpyrimidine, and imidazole) with RAGE is shown in 
Figure 1b. The CML compound binds to RAGE through 
six hydrogen bonds and four hydrophobic bonds on 
Gly121, Lys122, Pro123, Glu124, Val126, Val144, 
Ser145, and Glu146 residues of RAGE (Table 1). The 
total binding energy required to allow the formation of 
the interaction is −244.26 kJ/mol.
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Figure 1: (a) Ig-like C2-type 1 domain of advanced glycation end-
products receptor (RAGE). (b) Possible interactions between 
RAGE and four types of AGEs; carboxymethyllysine, argpyrimidine, 
pentosidine, and imidazole
a
b
The pentosidine compound binds to RAGE by 
two hydrogen bonds and one hydrophobic bond in the 
Ser209 and Arg216 amino acid residues, where the 
binding energy required for the interaction is lower than 
the energy required for CML interaction with RAGE, 
that is, −289.56 kJ/mol. In the interaction between the 
argpyrimidine compound and RAGE, no hydrogen bonds 
were formed at all, but seven hydrophobic interactions 
with the amino acids Ser290, Pro213, Arg214, Leu210, 
Gly211, Leu212, and Arg215 were formed. The total 
binding energy required for the interaction is −225.25 
kJ/mol, which is greater when compared with the 
energy required by CML and pentosidine to bind to 
RAGE. The imidazole compound requires the greatest 
energy to bind to RAGE when compared with the other 
AGEs of −97.22 kJ/mol, where this interaction formed 
six hydrophobic bonds with the amino acids Leu163, 
Lys168, Gly169, Thr170, Val193, and Thr194.
Possible interactions between the active 
components of G. mangostana with RAGE
To examine the possible ability of the active 
components of G. mangostana to inhibit AGE activity, it is 
necessary to analyze the docking between components 
of the active compound (α-mangostin, β-mangostin, 
mangostanol, garcinone D, 1,6-Dihydroxy-3,7-
dimethoxy-2-(3-methylbut-2-enyl)-xanthone, gartanin, 
γ-mangostin, 1-isomangostin, and 3-isomangostin) 
and RAGE. Visualization and analysis of docking 
interactions showed that of nine active compounds of 
G. mangostana, six of them are suspected to have the 
ability to inhibit the interaction between the imidazole 
and RAGE, which is known through competitive binding 
between the active components of G. mangostana and 
imidazole to bind to RAGE (Figure 1b). Six compounds 
include 1-isomangostin, 3-isomangostin, γ-mangostin, 
mangostanol, D-garcinone, and gartanin (Figure 2).
The binding energy required by the active 
components of G. mangostana to bind to RAGE is 
much smaller than the energy required by imidazole 
to interact. Binding energy required by the active 
components of 1-isomangostin, 3-isomangostin, 
γ-mangostin, mangostanol, D-garcinone, and gartanin 
is −262.49 kJ/mol, −256.47 kJ/mol, −262.87 kJ/mol, 
−255.87 kJ/mol, −253.14 kJ/mol, and −253.24 kJ/mol, 
respectively. Amino acids directly involved in the interaction 
process are completely listed in Table 2. Interaction 
analysis results showed that 1-isomangostin compound 
Table 1: AGEs and RAGE interactions
Molecule Point interaction Category Atomic donor Acceptor atom Binding energy
CML-RAGE GLU146: H -: CML: O Hydrogen bond A: GLU146: H CML: O −244.26 kJ/mol
CML: O - GLY121: O Hydrogen bond CML: O GLY121: O
CML: H - GLU146: OE2 Hydrogen bond CML: H GLU146: OE2
CML: H - GLY121: O Hydrogen bond CML: H GLY121: O
CML: H - GLU124: OE2 Hydrogen bond CML: H GLU124: OE2
CML: H - VAL144: O Hydrogen bond CML: H VAL144: O
CML: H - VAL126: O Hydrophobic bond CML: H VAL126: O
CML: H - PRO123: O Hydrophobic bond CML: H PRO123: O
CML: H - SER145: O Hydrophobic bond CML: H SER145: O
CML: H - LYS122: O Hydrophobic bond CML: H LYS122: O
Pentosidine-RAGE ARG216: HH21 - Pentosidine: O Hydrogen bond ARG216: HH21 Pentosidine: O −289.56 kJ/mol
ARG216: HH22 - Pentosidine: O Hydrogen bond ARG216: HH22 Pentosidine: O
Pentosidine: H-SER209: O Hydrophobic bond Pentosidine: H SER209: O
Argpyrimidine-RAGE Argpyrimidine: H - SER209: O Hydrophobic bond Argpyrimidine: H SER209: O −225.25 kJ/mol
Argpyrimidine: H - PRO213: O Hydrophobic bond Argpyrimidine: H PRO213: O
Argpyrimidine: H - ARG214: O Hydrophobic bond Argpyrimidine: H ARG214: O
Argpyrimidine: H - LEU210: O Hydrophobic bond Argpyrimidine: H LEU210: O
Argpyrimidine: H - GLY211: O Hydrophobic bond Argpyrimidine: H GLY211: O
Argpyrimidine: H - ARG215: O Hydrophobic bond Argpyrimidine: H ARG215: O
Argpyrimidine: H - LEU212: O Hydrophobic bond Argpyrimidine: H LEU212: O
Imidazole-RAGE Imidazole: H - LYS168: O Hydrophobic bond Imidazole: H LYS168: O −97.22 kJ/mol
Imidazole: H - THR170: O Hydrophobic bond Imidazole: H THR170: O
Imidazole: H - VAL193: O Hydrophobic bond Imidazole: H VAL193: O
Imidazole: H - LEU163: O Hydrophobic bond Imidazole: H LEU163: O
Imidazole: H - GLY169: O Hydrophobic bond Imidazole: H GLY169: O
Imidazole: H - THR194: O Hydrophobic bond Imidazole: H THR194: O
RAGE: Advanced glycation end-products receptor, AGEs: Advanced glycation end-products, CML: Carboxymethyllysine
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had competitive binding with imidazole on the amino 
acid residues of Leu163 and Val193; 3-isomangostin 
compounds on amino acid residues of Leu163, Lys168, 
Gly169, and Thr170; γ-mangostin compounds on the 
amino acid residues of Leu163, Lys168, Gly169, Val193, 
and Thr194; mangostanol compounds on amino acid 
residues of Leu163, Lys168, Gly169, Thr170, and Val193; 
D-garcinone compound on the amino acid residue of 
Leu163, Gly169, Thr170, Val193, and Thr194; and 
gartanin compounds on amino acid residues of Gly169, 
Val193, and Thr194.
Figure 2: Possible interaction between advanced glycation end-
products and nine active components of Garcinia mangostana L.
Interactions site of the six active components 
of G. mangostana with RAGE is located in the Ig-like 
C2-type 1 domain of the RAGE extracellular domain. 
Lower binding energy required by active components 
of G. mangostana to bind to RAGE when compared 
with imidazole compounds, as well as the similarity of 
interactions site between the components, suggests 
that the compounds of 1-isomangostin, 3-isomangostin, 
γ-mangostin, mangostanol, D-garcinone, and gartanin 
have potential to inhibit the interaction between AGEs 
(especially imidazole) and RAGE.
Discussion
The RAGE consists of three domains, 
the extracellular domain, transmembrane domain, 
and cytoplasmic domain. The extracellular domain 
itself is composed of Ig-like V-type domains, Ig-like 
C2-type 1 domains, and Ig-like C2-type 2 domain. The 
cytoplasmic domain is the C-terminal part required 
in the transduction signal mechanism in the cell [20]. 
Based on the results of UNIPROT analysis (uniprot.
org), the amino acid sequence of the RAGE domains 
starts with a signal recognition sequence consisting 
of 22 amino acids, which is then followed by an 
extracellular domain with a length of 319 amino acids, 
consisting of three domains: Ig-like V-type domain 
(amino acid residue No. 23-109), Ig-like C2-type 1 
domain (amino acid no. 123–219), and Ig-like C2-type 2 
domain (amino acid no. 233–315). The transmembrane 
domain is composed of 21 helix-shaped amino acids 
starting from amino acid numbers 342–362, while the 
cytoplasmic domain is composed of 40 amino acids 
which start from number 363–402 [21].
Results of this study reported that the many 
bonds formed between AGEs and RAGE are hydrogen 
bonds with hydrophobic bonds. The electrostatic 
attraction between polar molecules in the hydrogen 
bonds occurs when the hydrogen atom (H) binds to 
atoms having high electronegative properties such as 
nitrogen (N) or oxygen (O). The hydrogen bond is one of 
the strong bonds (5–30 kJ/mol), in which the hydrogen 
bonds are known to be stronger than Van der Waals and 
hydrophobic interactions [22]. This study also showed 
that all AGEs will bind to RAGE in the Ig-like C2-type 
1 domain, so it is suspected that this domain plays 
an important role in supporting the negative effects 
of AGE in the pathogenesis of diabetes and various 
other complications. Certain AGE compounds such as 
argpyrimidine and imidazole associated with their bond 
with RAGE are thought to play awfully essential role 
in increasing the complications of diabetes and chronic 
inflammatory diseases. Both the compounds when 
binding to RAGE can induce cellular transduction signal 
dysfunction through increased oxidative stress, as well 
as the synthesis and secretion of pro-inflammatory 
cytokines [23], [24].
G. mangostana L. has been widely known 
to contain various secondary metabolites such 
as prenylated and oxygenated xanthones [25]. 
Xanthones or xanthen-9H-ones are secondary 
metabolites found in some high-level plant families, 
fungi, and lichen [26], in which there is an important 
class of oxygenated heterocycles. Several types 
of xanthones present in mangosteen are including 
α-, β-, and γ-mangostin [27], [28], garcinone D [29], 
mangostanol [30], 1-isomangostin, 3-isomangostin [31], 
1,6-Dihydroxy-3,7-dimethoxy-2-(3-methylbut-2-enyl)-
xanthone, and gartanin [32]. The xanthone compounds 
present in mangosteen have various beneficial 
cellular activities, including antioxidant compounds, 
anti-inflammatory, anti-allergic, anti-bacterial, anti-
fungal, and many others [13]. Of the nine compounds 
of xanthones analyzed in this study, six of them 
are thought to inhibit AGE-RAGE activity through a 
competitive binding mechanism. The compounds 
include 1-isomangostin, 3-isomangostin, γ-mangostin, 
mangostanol, D-garcinone, and gartanin. Presumably 
through its ability to inhibit the interaction between AGE 
and RAGE, these compounds may play a role in inhibiting 
the pathogenesis of various inflammatory diseases. 
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γ-mangostin isolated from the pericarp of mangosteen 
fruit had inhibitor activity in the PGE2 secretory process. 
In addition to inhibiting the conversion of arachidonic 
acid to PGE2, the γ-mangostin compound may also 
inhibit the activity of cyclooxygenase-1 and -2 (COX-1 
and COX-2) enzymes [33].
Binding energy constitutes the energy required 
to allow the bonding between the ligand and the 
receptor, the lower the required energy the stronger 
and more stable the bonds formed. Conversely, if the 
energy required for bonding is greater, it will cause 
instability and difficulty in the bonding between receptor 
and ligand. In this study, the binding energy for AGEs 
and RAGE varies widely. Of some compounds of AGEs 
(CML, pentosidine, argpyrimidine, and imidazole), 
the compound having the lowest binding energy is 
pentosidine Σ: −289.56 kJ/mol, while the compound 
having the highest binding energy is imidazole Σ: 
−97.22 kJ/mol. Imidazole is an organic component of 
the formula C3H4N2 classified in the alkaloids class. 
Although the derivatives of imidazole are known to 
have some pharmacological activities such as anti-
depression, anti-viral, and anti-cancer [34], the presence 
of this compound which is one of the AGEs in some 
pathological conditions such as diabetic cataract and 
diabetic retinopathy is expected not to have beneficial 
effect so that the inhibition of activity of this compound 
Table 2: Active components of Garcinia mangostana and RAGE interaction
Molecule Point interaction Category Atomic donor Acceptor atom Binding energy
1,6-Dihydroxy-3,7-dimethoxy-2-(3-
methylbut-2-enyl)-xanthone
1,6 dihydroxy:O – LYS122:O Hydrophobic bond 1,6 dihydroxy:O LYS122: O −234.36 kJ/mol
1,6 dihydroxy:O – GLY121:O Hydrophobic bond 1,6 dihydroxy:O GLY121: O
1,6 dihydroxy:O – PRO120:O Hydrophobic bond 1,6 dihydroxy:O PRO120: O
1,6 dihydroxy:O – LEU184:O Hydrophobic bond 1,6 dihydroxy:O LEU184: O
1,6 dihydroxy:O – GLY147:O Hydrophobic bond 1,6 dihydroxy:O GLY147: O
1,6 dihydroxy:O – GLU146:O Hydrophobic bond 1,6 dihydroxy:O GLU146: O
1-isomangostin-RAGE 1-isomangostin: O – VAL140: O Hydrophobic bond 1-isomangostin:O VAL140: O −262.49 kJ/mol
1-isomangostin: O – TYR204:O Hydrophobic bond 1-isomangostin: O TYR204: O
1-isomangostin:O – PRO202:O Hydrophobic bond 1-isomangostin: O PRO202: O
1-isomangostin:O – PRO195:O Hydrophobic bond 1-isomangostin:O PRO195:O
1-isomangostin:O – LEU163:O Hydrophobic bond 1-isomangostin:O LEU163:O
1-isomangostin:O – VAL193:O Hydrophobic bond 1-isomangostin:O VAL193:O
3-isomangostin-RAGE 3-isomangostin:H – THR170:O Hydrophobic bond 3-isomangostin:H THR170:O −256.47 kJ/mol
3-isomangostin:H – GLY169:O Hydrophobic bond 3-isomangostin:H GLY169:O
3-isomangostin:O – LYS168:O Hydrophobic bond 3-isomangostin:O LYS168:O
3-isomangostin:O – LEU163:O Hydrophobic bond 3-isomangostin:O LEU163:O
α-mangostin-RAGE α-mangostin:O – GLY199:O Hydrogen bond α-mangostin:O GLY199:O −260.42 kJ/mol
α-mangostin:O – THR200:O Hydrophobic bond α-mangostin:O THR200:O
α-mangostin:O – THR201:O Hydrophobic bond α-mangostin:O THR201:O
α-mangostin:C – PRO202:O Hydrophobic bond α-mangostin:C PRO202:C
β-mangostin-RAGE β-mangostin:O – THR201:O Hydrogen bond β-mangostin:O THR201:O −266.73 kJ/mol
β-mangostin:C – GLY198:O Hydrophobic bond β-mangostin:C GLY198:O
β-mangostin:C – GLY199:O Hydrophobic bond β-mangostin:C GLY199:O
Mangostanol-RAGE Mangostanol:C – LYS168:O Hydrophobic bond Mangostanol:C LYS168:O −255.87 kJ/mol
Mangostanol:O – LEU163:O Hydrophobic bond Mangostanol:O LEU163:O
Mangostanol:C – GLY169:O Hydrophobic bond Mangostanol:C GLY169:O
Mangostanol:C – VAL193:O Hydrophobic bond Mangostanol:C VAL193:O
Mangostanol:C – THR170:O Hydrophobic bond Mangostanol:C THR170:O
γ-mangostin-RAGE γ-mangostin:O – PRO225:O Hydrogen bond γ-mangostin:O PRO225:O −262.87 kJ/mol
γ-mangostin:O – TYR204:O Hydrophobic bond γ-mangostin:O TYR204:O
γ-mangostin:O – LEU191:O Hydrophobic bond γ-mangostin:O LEU191:O
γ-mangostin:O – LEU163:O Hydrophobic bond γ-mangostin:O LEU163:O
γ-mangostin:O – VAL193:O Hydrophobic bond γ-mangostin:O VAL193:O
γ-mangostin:O – GLY169:O Hydrophobic bond γ-mangostin:O GLY169:O
γ-mangostin:O – THR170:O Hydrophobic bond γ-mangostin:O THR170:O
γ-mangostin:O – LYS168:O Hydrophobic bond γ-mangostin:O LYS168:O
γ-mangostin:O – THR194:O Hydrophobic bond γ-mangostin:O THR194:O
γ-mangostin:O – PRO195:O Hydrophobic bond γ-mangostin:O PRO:195:O
γ-mangostin:O – PRO202:O Hydrophobic bond γ-mangostin:O PRO202:O
γ-mangostin:O – LEU132:O Hydrophobic bond γ-mangostin:O LEU132:O
γ-mangostin:O – TYR204:O Hydrophobic bond γ-mangostin:O TYR204:O
D-garcinone-RAGE D-garcinone:H –THR194:O Hydrogen bond D-garcinone:H THR194:O −253.14 kJ/mol
D-garcinone:H –ASP159:O Hydrophobic bond D-garcinone:H ASP159:O
D-garcinone:H –THR201:O Hydrophobic bond D-garcinone:H THR201:O
D-garcinone:H –LEU158:O Hydrophobic bond D-garcinone:H LEU158:O
D-garcinone:H –GLY198:O Hydrophobic bond D-garcinone:H GLY198:O
D-garcinone:O –GLY199:O Hydrophobic bond D-garcinone:O GLY199:O
D-garcinone:O –ALA196:O Hydrophobic bond D-garcinone:O ALA196:O
D-garcinone:O –PRO195:O Hydrophobic bond D-garcinone:O PRO195:O
D-garcinone:O –PRO202:O Hydrophobic bond D-garcinone:O PRO202:O
D-garcinone:O –GLY169:O Hydrophobic bond D-garcinone:O GLY169:O
D-garcinone:O –VAL193:O Hydrophobic bond D-garcinone:O VAL193:O
D-garcinone:O –LEU163:O Hydrophobic bond D-garcinone:O LEU163:O
D-garcinone:O –THR170:O Hydrophobic bond D-garcinone:O THR170:O
Gartanin-RAGE Gartanin: H – THR194:O Hydrogen bond Gartanin: H THR194:O −253.24 kJ/mol
Gartanin: H – GLY169:O Hydrophobic bond Gartanin: H GLY169:O
Gartanin: H – ALA196:O Hydrophobic bond Gartanin: H ALA196:O
Gartanin: H – GLY198:O Hydrophobic bond Gartanin: H GLY198:O
Gartanin: H – PRO202:O Hydrophobic bond Gartanin: H PRO202:O
Gartanin: H – LEU158:O Hydrophobic bond Gartanin: H LEU158:O
Gartanin: H – PRO195:O Hydrophobic bond Gartanin: H PRO195:O
Gartanin: H – VAL193:O Hydrophobic bond Gartanin: H VAL193:O
Mangostanol-RAGE Mangostanol:C – LYS168:O Hydrophobic bond Mangostanol:C LYS168:O −255.87 kJ/mol
Mangostanol:O – LEU163:O Hydrophobic bond Mangostanol:O LEU163:O
Mangostanol:C – GLY169:O Hydrophobic bond Mangostanol:C GLY169:O
Mangostanol:C – VAL193:O Hydrophobic bond Mangostanol:C VAL193:O
Mangostanol:C – THR170:O Hydrophobic bond Mangostanol:C THR170:O
RAGE: Advanced glycation end-products receptor, AGEs: Advanced glycation end-products, CML: Carboxymethyllysine
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is thought to prevent the occurrence of complications 
caused by the interaction of this compound and its 
receptor, RAGE.
Conclusions
The six xanthones, namely, 1-isomangostin, 
3-isomangostin, γ-mangostin, mangostanol, D-garcinone, 
and gartanin potentially could inhibit the interaction and 
activity of imidazole in RAGE through a competitive 
binding mechanism. In this case, the inhibition of 
imidazole-RAGE activity by the mangosteen active 
components may inhibit the pathobiology of the AGE-
RAGE axis.
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